BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li B, Xie D, Zhang H. Long non-coding RNA GHET1 contributes to chemotherapeutic resistance to Gemcitabine in bladder cancer. Cancer Chemother Pharmacol 2019;84:187-94. [PMID: 31115606 DOI: 10.1007/s00280-019-03873-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao S, Shan L, Zhang M, Wang Y, Zhan X, Yin Y, Jiang Z, Tao X, Li X, Ye M, Liu Y. Inhibition of PP2A by LB100 sensitizes bladder cancer cells to chemotherapy by inducing p21 degradation. Cell Oncol (Dordr) 2022. [PMID: 36136269 DOI: 10.1007/s13402-022-00710-8] [Reference Citation Analysis]
2 Lee HW, Kang MJ, Kwon Y, Abdi Nansa S, Jung EH, Kim SH, Lee S, Jeong K, Kim Y, Cheong H, Seo HK. Targeted Inhibition of O-Linked β-N-Acetylglucosamine Transferase as a Promising Therapeutic Strategy to Restore Chemosensitivity and Attenuate Aggressive Tumor Traits in Chemoresistant Urothelial Carcinoma of the Bladder. Biomedicines 2022;10:1162. [DOI: 10.3390/biomedicines10051162] [Reference Citation Analysis]
3 Liu Y, Shi P, Fang H, Zhao Z, Yang F, Zhang J, Jing S, Geng C. Long non-coding RNA GHET1 promotes thyroid cancer cell proliferation and invasion. Transl Cancer Res 2021;10:4148-57. [PMID: 35116711 DOI: 10.21037/tcr-21-1615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang Y, Chen X, Lin J, Jin X. Biological functions and clinical significance of long noncoding RNAs in bladder cancer. Cell Death Discov 2021;7:278. [PMID: 34611133 DOI: 10.1038/s41420-021-00665-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Mirzaei S, Paskeh MDA, Hashemi F, Zabolian A, Hashemi M, Entezari M, Tabari T, Ashrafizadeh M, Raee P, Aghamiri S, Aref AR, Leong HC, Kumar AP, Samarghandian S, Zarrabi A, Hushmandi K. Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies. Life Sci 2021;:119948. [PMID: 34520771 DOI: 10.1016/j.lfs.2021.119948] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
6 Lu Q, Chen W, Ji Y, Liu Y, Xue X. Ursolic Acid Enhances Cytotoxicity of Doxorubicin-Resistant Triple-Negative Breast Cancer Cells via ZEB1-AS1/miR-186-5p/ABCC1 Axis. Cancer Biother Radiopharm 2021. [PMID: 33493421 DOI: 10.1089/cbr.2020.4147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Zangouei AS, Rahimi HR, Mojarrad M, Moghbeli M. Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells. Diagn Pathol 2020;15:136. [PMID: 33183321 DOI: 10.1186/s13000-020-01054-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
8 Zhou X, Fan Y, He Y, Mou A, Wang F, Liu Y, Wu Z. Clinicopathological and Prognostic Value of Gastric Carcinoma Highly Expressed Transcript 1 in Cancer: A Meta-Analysis. J Oncol 2020;2020:6341093. [PMID: 32908508 DOI: 10.1155/2020/6341093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Barth DA, Juracek J, Slaby O, Pichler M, Calin GA. lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System. Cancers (Basel) 2020;12:E2148. [PMID: 32756406 DOI: 10.3390/cancers12082148] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
10 Jin KT, Lu ZB, Lv JQ, Zhang JG. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer. RNA Biol 2020;17:1727-40. [PMID: 32129701 DOI: 10.1080/15476286.2020.1737787] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
11 Wang B, Guan G, Zhao D. Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/β-catenin signaling pathway. Biomed Pharmacother 2020;125:109961. [PMID: 32028241 DOI: 10.1016/j.biopha.2020.109961] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
12 Zheng F, Xu R. CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis. Biomed Pharmacother 2020;124:109828. [PMID: 31986409 DOI: 10.1016/j.biopha.2020.109828] [Cited by in Crossref: 40] [Cited by in F6Publishing: 49] [Article Influence: 20.0] [Reference Citation Analysis]
13 Xie F, Zhao N, Zhang H, Xie D. Circular RNA CircHIPK3 Promotes Gemcitabine Sensitivity in Bladder Cancer. J Cancer 2020;11:1907-12. [PMID: 32194801 DOI: 10.7150/jca.39722] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]
14 Antonova O, Rukova B, Mladenov B, Rangelov S, Hammoudeh Z, Nesheva D, Staneva R, Spasova V, Grigorov E, Hadjidekova S, Slavov C, Toncheva D. Expression profiling of muscle invasive and non-invasive bladder tumors for biomarkers identification related to drug resistance, sensitivity and tumor progression. Biotechnology & Biotechnological Equipment 2020;34:506-514. [DOI: 10.1080/13102818.2020.1778528] [Reference Citation Analysis]